ACTON, Mass., Oct. 4 /PRNewswire-FirstCall/ -- Psychemedics Corporation (AMEX: PMD) today announced that Jennifer Chmieleski has joined the company as Vice President, Controller.
Jennifer will be responsible for all internal and external financial reporting activities, as well as the financial analysis and planning activities necessary for the company's continued growth. Jennifer will report directly to the Chairman and CEO.
Since 1999, Jennifer has served as Controller and Assistant Controller of Edgewater Technology, Inc, a publicly traded, technology management consulting firm, with 2006 annual revenue of approximately $60 million. Prior to her position at Edgewater, Jennifer worked for over four years in public accounting. She is a CPA who received her Bachelor of Science in Accountancy from Bentley College in 1995.
Raymond C. Kubacki, Chairman and CEO stated, "We are extremely pleased to have Jennifer join our team. She comes to us with a strong proven track record that fits extremely well with the needs of our company. Her strong analytical skills will be very important in determining and controlling costs and expenses, as well as analyzing other key metrics in our business needed to accelerate our growth. Jennifer will be our top financial officer and we are extremely pleased to have her on board."
Psychemedics is the world's largest provider of testing for drugs of abuse using hair analysis with thousands of corporations relying on the patented Psychemedics drug testing services. Psychemedics' clients include over 10% of the Fortune 500, some of the largest police departments in America and Federal Reserve Banks.
The Psychemedics web site is http://www.drugtestwithhair.com
Cautionary Statement for purposes of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995: From time to time, information provided by Psychemedics may contain forward-looking information that involves risks and uncertainties. In particular, statements contained in this release that are not historical facts (including but not limited to statements concerning growth, earnings, profit margins, earnings per share, revenues, dividends, future business, new accounts, customer base, market share, test volume and sales and marketing strategies) may be "forward looking" statements. Actual results may differ from those stated in any forward-looking statements. Factors that may cause such differences include but are not limited to risks associated with the expansion of the Company's sales and marketing network, development of markets for new products and services offered, the economic health of principal customers of the Company, government regulation, including but not limited to FDA regulations, competition and general economic conditions and other factors disclosed in the Company's filings with the Securities and Exchange Commission.
Raymond C. Kubacki
Chairman, President and CEO
|SOURCE Psychemedics Corporation|
Copyright©2007 PR Newswire.
All rights reserved